Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Dec 5, 2016
Insider Transaction Report
Form 4
Myers Diane
Senior VP-Reg./Quality
Transactions
- Exercise/Conversion
Common Stock
2016-12-01+2,500→ 4,060 total - Tax Payment
Common Stock
2016-12-01$6.48/sh−777$5,035→ 3,283 total
Footnotes (1)
- [F1]On December 1, 2016, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 2,500 performance-based restricted stock units, which were converted into 2,500 shares of common stock on a one-for-one basis.